HK Stock MarketDetailed Quotes
02616 CSTONE PHARMA-B
Watchlist
2.130
+0.080+3.90%
Trading 12/06 15:30 CST
2.220High2.040Low3.65MVolume
2.060Open2.050Pre Close7.85MTurnover0.28%Turnover RatioLossP/E (TTM)2.74BMarket Cap6.22052wk HighLossP/E (Static)1.28BShares1.62052wk Low4.18P/B2.74BFloat Cap19.120Historical High--Dividend TTM1.28BShs Float1.620Historical Low--Dividend LFY8.78%Amplitude--Div YieldTTM2.152Avg Price500Lot Size--Div Yield LFY
CSTONE PHARMA-B Key Stats
All
YOY

(Q6)2023/06/30 | (FY)2022/12/31 | (Q6)2022/06/30 | (FY)2021/12/31 | (Q6)2021/06/30 | (FY)2020/12/31 | (Q6)2020/06/30 | (FY)2019/12/31 | (Q6)2019/06/30 | (FY)2018/12/31 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 42.13%-209.23M | 52.99%-902.68M | 53.28%-361.57M | -57.26%-1.92B | -15.29%-773.85M | 47.11%-1.22B | 45.68%-671.24M | -28.74%-2.31B | ---1.24B | -423.47%-1.79B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 1.34%-9.67M | ---- | 59.43%-9.8M | ---- | 64.09%-24.16M | 6.11%-20.44M | -746.70%-67.29M | ---21.77M | -126.54%-7.95M |
Impairment and provisions: | --0 | 41.71%31.13M | --0 | --21.97M | --0 | --0 | --0 | --0 | --0 | --0 |
-Impairmen of inventory (reversal) | ---- | -64.88%7.72M | ---- | --21.97M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | --23.41M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Revaluation surplus: | --0 | -3.54%61.93M | --0 | 2,756.35%64.2M | --0 | -100.32%-2.42M | -100.29%-2.18M | -14.22%748.74M | --751.35M | 1,083.05%872.82M |
-Other fair value changes | ---- | -3.54%61.93M | ---- | 2,756.35%64.2M | ---- | -100.32%-2.42M | -100.29%-2.18M | -14.22%748.74M | --751.35M | 14,278.35%872.82M |
Asset sale loss (gain): | --0 | --0 | --0 | --901K | --0 | --0 | --0 | 49.61%-654K | --0 | -586.14%-1.3M |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | --901K | ---- | ---- | ---- | --104K | ---- | ---- |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 41.60%-758K | ---- | ---1.3M |
Depreciation and amortization: | --0 | 96.55%44.54M | --0 | 53.10%22.66M | --0 | 27.82%14.8M | 41.42%7.33M | 119.90%11.58M | --5.18M | 541.41%5.27M |
-Depreciation | ---- | 88.51%31.88M | ---- | 40.62%16.91M | ---- | 6.55%12.03M | 18.61%6.01M | 121.10%11.29M | --5.06M | 529.47%5.11M |
-Amortization of intangible assets | ---- | 120.19%12.66M | ---- | 107.21%5.75M | ---- | 847.10%2.78M | 1,020.34%1.32M | 81.99%293K | --118K | 1,510.00%161K |
Financial expense | ---- | 278.10%8.48M | ---- | 69.85%2.24M | ---- | 335.64%1.32M | --238K | --303K | ---- | ---- |
Exchange Loss (gain) | ---- | -188.95%-61.49M | ---- | -61.98%69.13M | ---- | 264.23%181.84M | 47.29%-31.79M | 14.53%-110.72M | ---60.31M | -539.50%-129.54M |
Special items | -76.16%26.93M | -36.62%142.65M | -36.96%112.96M | -36.70%225.07M | 10.23%179.18M | -13.26%355.57M | -18.94%162.55M | 74.55%409.93M | --200.52M | 736.11%234.85M |
Operating profit before the change of operating capital | 26.67%-182.3M | 55.04%-685.12M | 58.19%-248.61M | -119.54%-1.52B | -7.04%-594.67M | 47.28%-694.05M | -53.96%-555.54M | -60.75%-1.32B | ---360.83M | -283.48%-818.98M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | -48.49%821K | 135.30%30.42M | 105.29%1.59M | ---86.18M | ---30.14M | ---- | ---- | ---- | ---- | ---- |
Accounts receivable (increase)decrease | -134.19%-108.73M | 134.41%40.47M | 7.92%-46.43M | ---117.6M | ---50.42M | ---- | ---- | ---- | ---- | ---- |
Accounts payable increase (decrease) | -54.20%-134.57M | -102.03%-3.1M | 66.84%-87.27M | -40.63%153.08M | -131.41%-263.17M | -27.19%257.81M | -1,187.33%-113.72M | 437.44%354.06M | ---8.83M | 326.86%65.88M |
prepayments (increase)decrease | 225.77%78.87M | -113.17%-11.66M | -175.92%-62.71M | 221.36%88.49M | 233.72%82.6M | 42.47%-72.91M | 206.84%24.75M | -215.39%-126.73M | ---23.17M | -1,759.77%-40.18M |
Cash from business operations | 21.99%-345.91M | 57.67%-628.99M | 48.19%-443.42M | -191.85%-1.49B | -32.78%-855.81M | 53.26%-509.15M | -64.07%-644.51M | -37.30%-1.09B | ---392.83M | -230.28%-793.29M |
Special items of business | --5.08M | 761.31%16.52M | ---- | 77.59%1.92M | ---- | -87.29%1.08M | -5.15%2.97M | 289.91%8.5M | --3.13M | --2.18M |
Net cash from operations | 23.14%-340.83M | 58.73%-612.47M | 48.19%-443.42M | -192.09%-1.48B | -33.40%-855.81M | 52.99%-508.07M | -64.63%-641.54M | -36.61%-1.08B | 19.15%-389.7M | -229.37%-791.11M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 886.35%15.39M | -0.21%9.67M | -77.71%1.56M | -57.61%9.69M | -65.76%7M | -41.70%22.86M | 233.06%20.44M | 667.33%39.22M | 38.60%6.14M | -15.58%5.11M |
Decrease in deposits (increase) | -25.02%382.47M | 177.84%394.32M | 44.03%510.06M | -141.37%-506.6M | -70.32%354.12M | 258.13%1.22B | 234.23%1.19B | -2.33%-774.36M | ---889M | ---756.71M |
Purchase of fixed assets | ---- | ---- | 66.87%-217K | -171.59%-85.9M | 94.14%-655K | -409.06%-31.63M | -600.19%-11.17M | 11.39%-6.21M | 35.16%-1.6M | 42.19%-7.01M |
Purchase of intangible assets | ---- | -61.02%-101.82M | -22.96%-71.68M | -58.81%-63.24M | -1,758.99%-58.3M | -5,580.17%-39.82M | -4,511.76%-3.14M | 16.15%-701K | 89.59%-68K | -274.89%-836K |
Recovery of cash from investments | ---- | 585.34%69.39M | ---- | 55.96%10.13M | ---- | -94.33%6.49M | -94.29%4.98M | -82.46%114.53M | -73.27%87.2M | -83.75%653.06M |
Cash on investment | ---- | 96.57%-6.54M | 50.61%-8.14M | -5,143.29%-190.65M | -141.72%-16.48M | 90.59%-3.64M | -16.57%-6.82M | 86.52%-38.62M | 97.46%-5.85M | 92.35%-286.42M |
Other items in the investment business | -85.26%84K | 890.00%99K | 9,400.00%570K | -99.50%10K | -99.70%6K | -72.61%1.99M | -61.27%1.98M | -51.90%7.27M | --5.12M | 10,245.89%15.11M |
Net cash from investment operations | -7.92%397.94M | 144.17%365.12M | 51.26%432.15M | -170.00%-826.55M | -76.18%285.7M | 279.20%1.18B | 250.32%1.2B | -74.45%-658.88M | -920.47%-798.05M | -240.78%-377.7M |
Net cash before financing | 606.51%57.11M | 89.29%-247.35M | 98.02%-11.28M | -443.50%-2.31B | -202.16%-570.11M | 138.67%672.66M | 146.98%558.06M | -48.84%-1.74B | -208.74%-1.19B | -4,257.39%-1.17B |
Cash flow from financing activities | ||||||||||
New borrowing | 666.75%100M | 17.49%113.04M | -24.51%13.04M | 64.24%96.22M | -28.22%17.28M | --58.58M | --24.07M | ---- | ---- | ---- |
Refund | -2,193.83%-154.28M | -377.18%-32M | -317.25%-6.73M | -324.43%-6.71M | -571.67%-1.61M | ---1.58M | ---240K | ---- | ---- | ---- |
Issuing shares | 50,881.49%341.58M | -84.97%2.53M | -93.73%670K | -98.76%16.83M | 291.57%10.68M | -38.07%1.36B | -99.88%2.73M | 11.44%2.2B | 33.26%2.2B | --1.97B |
Interest paid - financing | 6.27%-5.87M | -426.67%-11.81M | -185.25%-6.27M | -69.85%-2.24M | -1,686.18%-2.2M | -335.64%-1.32M | 17.45%-123K | ---303K | ---149K | ---- |
Issuance expenses and redemption of securities expenses | ---3.31M | ---- | ---- | ---- | ---- | 78.46%-21.8M | 78.38%-21.83M | -4,300.04%-101.2M | ---100.95M | ---2.3M |
Other items of the financing business | 31.18%-12.44M | -267.13%-43.3M | -265.79%-18.07M | -119.16%-11.79M | -64.72%-4.94M | -14.90%-5.38M | -62.55%-3M | 98.48%-4.68M | ---1.85M | ---307.22M |
Net cash from financing operations | 1,631.17%265.67M | -69.16%28.47M | -190.34%-17.35M | -93.36%92.3M | 1,097.38%19.21M | -33.56%1.39B | -99.92%1.6M | 25.80%2.09B | 27.01%2.09B | 554,240.00%1.66B |
Effect of rate | 42.61%24.76M | 154.83%34.84M | 165.59%17.36M | 61.24%-63.55M | -154.82%-26.47M | -323.48%-163.98M | -9.83%48.28M | -40.99%73.37M | -15.41%53.55M | 3,237.37%124.33M |
Other items affecting net cash | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1K | ---- |
Net Cash | 1,227.59%322.78M | 90.13%-218.88M | 94.80%-28.63M | -207.57%-2.22B | -198.43%-550.9M | 486.28%2.06B | -38.21%559.67M | -28.74%351.73M | -28.32%905.69M | 1,674.69%493.61M |
Begining period cash | -24.78%558.68M | -75.44%742.72M | -75.44%742.72M | 168.51%3.02B | 168.51%3.02B | 60.61%1.13B | 60.61%1.13B | 741.03%701.34M | 741.03%701.34M | 40.06%83.39M |
Cash at the end | 23.89%906.22M | -24.78%558.68M | -70.11%731.46M | -75.44%742.72M | 41.10%2.45B | 168.51%3.02B | 4.44%1.73B | 60.61%1.13B | 17.76%1.66B | 741.03%701.34M |
Cash balance analysis | ||||||||||
Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--